中药复方发明专利创造性审查的影响因素分析
投稿时间:2023-04-20  修订日期:2023-05-30   点此下载全文
引用本文:
DOI:
摘要点击次数: 46
全文下载次数: 0
                    
作者中文名作者英文名单位中文名单位英文名E-Mail
曹雅迪 CAO Ya-di 北京北中岐黄科技投资管理有限公司 Beijing Beizhong Qihuang Technology Investment Management Co,Ltd caoyadi@vip.163.com 
陈宁 CHEN Ning 北京中医药大学成果转化中心 Achievement Transformation Center,Beijing University of Chinese Medicine 15652387968@163.com 
刘盼 LIU Pan 北京中医药大学图书馆
北京中医药大学图书馆
Beijing University of Chinese Medicine Libraries panliu@vip.163.com 
洪峰 HONG Feng 广东省中医院 Guangdong Provincial Hospital of Traditional Chinese Medicine 15101633255@163.com 
王铁融 WANG Tie-rong 北京中医药大学管理学院 School of Management, Beijing University of Chinese Medicine 392170753@qq.com 
侯媛媛 HOU Yuan-yuan 北京中医药大学管理学院 School of Management, Beijing University of Chinese Medicine houyuanyuan0223@163.com 
刘伟* LIU Wei 北京中医药大学管理学院 School of Management, Beijing University of Chinese Medicine, nolanlucky@163.com 
基金项目:]教育部人文社会科学研究青年基金项目(基于中药创新主体保护需求的中药专利审查标准研究18YICZH106)资助*[通信作者] 刘伟,副教授,研究方向医药知识产权保护与成果转化研究;Tel:13681241660,E-mail:nolanlucky@163.com
中文摘要:目的:分析专利创造性审查的影响因素并深入探讨原因,以期为完善中药复方发明专利的创造性审查标准提供相关参考。 方法:基于中药复方发明专利复审决定数据,运用单因素Logistic回归分析复审决定结果的影响因素。 结果:创造性审查标准受到年度变化的明显影响,在专利复审阶段申请人补充实验数据的撤销驳回决定的概率是未补充实验数据的2.323倍。 结论:我国尚未建立合理、统一、清晰的中药复方发明专利创造性审查标准。采用补充实验数据的方式加以说明其专利申请的技术方案产生了预料不到的技术效果将提高专利复审撤销驳回决定的概率。区别技术特征数量和审查员所引用的对比文件及公知常识情况亦对创造性审查结果产生影响。
中文关键词:中药复方  发明专利  复审决定  影响因素
 
Analysis of the influencing factors of patent inventive examination of traditional Chinese medicine composition
Abstract:Objective:To analyze the influencing factors of patent inventive examination and explore the reasons, in order to provide relevant references for improving the inventive examination standards of traditional Chinese medicine compound invention patents. Methods:Based on the data of patent reexamination decisions of traditional Chinese medicine composition, the Logistic regression analysis was used to empirically analyze the influencing factors of the reexamination decisions. Results:The inventive examination standard is significantly affected by the annual change. In the patent reexamination stage, the probability of redrawing the rejection decisions by the applicants to supplement experimental data was 2.323 times that of the applicants did not supplement the experimental data. Conclusion:China has not established a reasonable, unified and clear inventive examination standard for Chinese medicine composition patents. Demonstrating that the invention of the application has produced an unexpected technical effect by supplementing the experimental data will increase the probability of redrawing the rejection decision. The number of different technical features, the comparison of documents and common knowledge cited by examiners also influenced the results of inventive examination.
keywords:Chinese medicine composition  patent  reexamination decisions  Influencing factors
查看全文   查看/发表评论  下载PDF阅读器